CANADA | Canadian company developing a cannabis cure for a rare type of skin cancer

The company has also signed an exclusive licensing agreement with National Medical Cannabis Research Lab at Agricultural Research Organization (ARO)—the Volcani Center, Israel.
The company has also signed an exclusive licensing agreement with National Medical Cannabis Research Lab at Agricultural Research Organization (ARO) – the Volcani Center, Israel. scanrail / iStock / Getty Images Plus

A Canadian company is developing a cannabis-centric solution for Cutaneous T-cell lymphoma (CTCL), an uncommon type of cancer occurring in adults aged 40 to 60 and sometimes in children.

READ MORE BELOW:

Source: http://bit.ly/2F65vue reposted by Cannabis News World . Original article by Anisha Dhiman

NuMeds superior strength logo banner hi res 300dpi

Advertisements

This site uses Akismet to reduce spam. Learn how your comment data is processed.